Relmada Therapeutics Inc
Relmada Therapeutics Inc (RLMD) Option Chain
As of September 23, 2026, Relmada Therapeutics Inc is trading at $3.80, a +0.53% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 134.5%. IV Rank is 62%.
Read more
Tracking the RLMD option chain helps you see every strike and expiry on Relmada Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Relmada Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RLMD options activity at a glance. Use our scanner to monitor the RLMD option chain in real time and filter for the RLMD options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RLMD stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the RLMD option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where RLMD stock options are being actively traded and where they are not.
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Relmada Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen RLMD options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of RLMD stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile82.54% Elevated
- Market cap (M$)403
- 52 weeks high-52.75%
- 52 weeks low148.68%
- Analyst recommendationStrong Buy
1.00 - Target price$10.75
226.32% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-0.93
- EPS growth next 5 years20.09%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.01 | 3 | 0 | 0.33 | 1.30 | 1.25 | 2.00 | 2.50 | -41.04 | — | 0.50 | 0.00 | 0.50 | 0 | 0 | 99.99 |
| 89.32 | 149 | 0 | 0.10 | 0.00 | — | 0.10 | 5.00 | +17.92 | 0.60 | 1.10 | 1.20 | -0.35 | 0 | 0 | 10.68 |
| 100.00 | 1 | 0 | 0.50 | 0.00 | — | 0.50 | 7.50 | +76.89 | 2.85 | 3.70 | 3.70 | -0.43 | 0 | 0 | 0.00 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full RLMD option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→